Emergent gets $23m additional order for vaccine production
An American multinational specialty biopharmaceutical company, Emergent BioSolutions Inc has said that a key U.S. agency has increased an order, related to the manufacturing of Johnson & Johnson's COVID-19 vaccine, by $23 million.…